SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

Iris Energy Ltd

IREN is trending due to positive analyst coverage and increasing optimism around its AI cloud scaling potential, with the community discussing price targets and the possibility of a short squeeze. Bullish investors believe IREN is undervalued and poised for significant growth, while others express concern about its valuation and potential pullback. Discussions also involve comparisons to peers like CIFR and NBIS, and speculation about future deals and market dynamics.

bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. The company was founded on March 26, 2014 and is headquartered in San Antonio, TX.

BioAffinity Technologies Inc

BioAffinity Technologies is trending due to recent case studies showcasing the effectiveness of its CyPath Lung test in early lung cancer detection, potentially reducing the need for invasive procedures. The community is actively discussing the company's fresh story and the potential for a significant upside given its low float. Some traders are setting high price targets while others are cautious about possible dilution.

Ford Motor Co. engages in the manufacture, distribution, and sale of automobiles. It operates through the following segments: Ford Blue, Ford Model E, Ford Pro, Ford Next, Ford Credit, and Corporate Other. The Ford Blue, Ford Model E, and Ford Pro segment includes the sale of Ford and Lincoln vehicles, service parts, and accessories, together with the associated costs to develop, manufacture, distribute, and service the vehicles, parts, and accessories. The Ford Next segment is involved in the expenses and investments for emerging business initiatives aimed at creating value for Ford in vehicle-adjacent market segments. The Ford Credit segment consists of the Ford Credit business on a consolidated basis, which is primarily vehicle-related financing and leasing activities. The Corporate Other segment refers to corporate governance expenses, past service pension and OPEB income and expense, interest income and gains and losses from cash, cash equivalents, and marketable securities, and foreign exchange derivatives gains, and losses associated with intercompany lending. The company was founded by Henry Ford on June 16, 1903 and is headquartered in Dearborn, MI.

Ford Motor Co.

Ford Motor Co

Ford is trending as anticipation builds for a major announcement expected on Monday, sparking community speculation about a potential "Model T moment" related to EVs. The community is actively discussing the potential impact of this announcement, with some expressing skepticism given the company's history and others suggesting partnerships or product innovations may be unveiled. Broader market factors, such as tariffs and potential impact on EVs, are also part of the conversation.

Cipher Mining, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Mining Inc

Cipher Mining is trending due to a recent multi-billion dollar AI compute deal, with community members actively discussing the financial backing from Google and the potential impact on shareholder value. Despite positive news, the stock experienced a sell-off, leading to debates around market manipulation, dilution concerns, and future price targets. Some investors view the dip as a buying opportunity, citing the company's strategic shift towards high-performance computing and long-term growth potential in the AI sector.

Eastman Kodak Co. engages in the provision of analog and digital innovations. It operates through the following segments: Traditional Printing, Digital Printing, Advanced Materials and Chemicals, and Brand. The Traditional Printing segment consists of Prepress Solutions, which includes Kodak's digital offset plate offerings and computer-to-plate imaging solutions. The Digital Printing segment contains Electrophotographic Printing Solutions, Prosper, Versamark and Software. The Advanced Materials and Chemicals segment consists of four lines of business: Industrial Film and Chemicals, Motion Picture, Advanced Materials and Functional Printing, and Kodak Services for Business (KSB). The Brand segment includes licensing of the Kodak brand to third parties. The company was founded by George Eastman in 1880 and is headquartered in Rochester, NY.

Eastman Kodak Co.

Eastman Kodak ($KODK) is trending amid community discussion around its pharmaceutical manufacturing capabilities and potential benefits from new pharmaceutical tariffs.  Some investors are optimistic about a short squeeze due to high short interest, while others express skepticism based on past performance. The community is actively monitoring for news related to government contracts and the finalization of pension assets.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is trending as community members discuss potential catalysts related to reshoring chip manufacturing and government support, possibly including mandates. Optimism is fueled by reported interest from major tech players and significant investment, with some speculating about a potential return to previous highs and beyond. Community members are actively debating the sustainability of the rally and the impact of government policies.

Crinetics Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its product candidate, CRN00808, is an oral nonpeptide somatostatin agonist for the treatment of acromegaly. The firm is also developing other oral nonpeptide somatostatin agonists for neuroendocrine tumors and hyperinsulinism, as well as an oral nonpeptide ACTH antagonist for the treatment of Cushing's disease. The company was founded by R. Scott Struthers, Yun-Fei Zhu and Stephen F. Betz in 2008 and is headquartered in San Diego, CA.

Crinetics Pharmaceuticals Inc

CRNX is trending as traders discuss a potential short squeeze following FDA approval of PALSONIFY, an oral treatment for acromegaly. Community members are debating whether short sellers will be forced to cover their positions and are eyeing potential price target upgrades. Some traders believe retail investors can influence the price if they avoid selling at market prices, while others discuss the potential market size and competition.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is trending as community members discuss its recent performance, potential long-term investment opportunities, and upcoming earnings, with some highlighting the new SKIMS collaboration and others pointing to a downtrend. Community members are weighing positive retail surprises and analyst upgrades against concerns about tariffs and revenue decline. Several analysts raised their price target for Nike, citing a stronger revenue recovery due to new products and World Cup sales.

Costco Wholesale Corp. engages in the provision of operation of membership warehouses through wholly owned subsidiaries. It operates through the following geographical segments: United States, Canada, and Other International Operations. The company was founded by James D. Sinegal and Jeffrey H. Brotman in 1983 and is headquartered in Issaquah, WA.

Costco Wholesale Corp

Costco is trending amid mixed reactions to its Q4 earnings, which beat EPS estimates but slightly missed revenue expectations. While some investors express concerns about the company's valuation, tariffs, and competition from Amazon, others highlight its strong membership model and consistent earnings. The community is actively debating whether to buy the dip, with opinions split between those seeing long-term upside and those anticipating a correction.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending following positive Phase 3 trial results for its oral Wegovy pill, showing similar weight loss to the injectable version, which could broaden its market reach. The community is discussing the implications for market dominance and potential competition with Eli Lilly, as well as the convenience and accessibility the pill form offers. Some investors are seeing the company's stock as undervalued.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Clinical-stage biotech focused on cardiovascular, central nervous system, inflammatory and metabolic diseases. Their leading drug candidate is lorcaserin hydrochloride, which recently received positive data from a clinical trial. They are headquartered in San Diego, CA.

Arena Pharmaceuticals Inc

Will the U.S. government shut down in 2025? 
 
*Powered by Polymarket

Current Price	$99.99
Prev Close	$99.93
Open	$99.97
Dividend Yield	N/A
50-Day Moving Average	$93.35
Beta	0.79
Avg. Volume	1.04M
PE Ratio	-9.87

52-Week High	$100.00
52-Week Low	$45.50
Market Capitalization	$6.17B
EPS (Annual)	N/A
Price to Book	9.14
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

ARNA
Arena Pharmaceuticals Inc

Feed

News

Sentiment

Fundamentals

Info

Latest ARNA News

ARNA Arena Pharmaceuticals Inc